Trajan Group Holdings Ltd (ASX: TRJ) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Trajan Group Holdings Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$102.96 million
P/E Ratio
87.92
Dividend Yield
0.00%
Shares Outstanding
152.54 million
Earnings per share
-0.029
Dividend per share
N/A
Year To Date Return
-4.29%
Earnings Yield
1.14%
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Trajan Group Holdings Ltd (ASX: TRJ)
Latest News
Healthcare Shares
Is this ASX healthcare stock a buy low candidate after falling 35%?
Broker Notes
Broker says this penny stock could rise 50%!
Healthcare Shares
3 ASX health care shares that outpaced the market on Friday
Share Gainers
The Trajan (ASX:TRJ) share price is up 38% in under two weeks
TRJ ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Trajan Group Holdings Ltd
Trajan Group Holdings Ltd is a developer and manufacturer of analytical and life sciences products and devices, seeking to enrich human well-being through scientific measurement. Its current portfolio of products comprises products, devices and solutions that are used in the analysis of biological, food, and environmental samples. The Group now reports in three operating segments: Components and Consumables, Capital Equipment and Disruptive Technologies. Key revenue is generated from Components and consumables, which include parts, supplies, components, and consumable products worldwide. The Group operates in Asia (Malaysia, Japan and Australia and New Zealand (ANZ)), USA and Europe, Middle East, Africa, and India (EMEA).
TRJ Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 06 Feb 2026 | $0.68 | $0.01 | 1.49% | 17,985 | $0.69 | $0.69 | $0.67 |
| 05 Feb 2026 | $0.67 | $0.00 | 0.00% | 38,202 | $0.67 | $0.68 | $0.67 |
| 04 Feb 2026 | $0.67 | $0.00 | 0.00% | 119,887 | $0.67 | $0.68 | $0.65 |
| 03 Feb 2026 | $0.67 | $0.01 | 1.50% | 120,905 | $0.68 | $0.69 | $0.67 |
| 02 Feb 2026 | $0.67 | $0.03 | 4.72% | 15,763 | $0.65 | $0.67 | $0.65 |
| 29 Jan 2026 | $0.64 | $-0.02 | -3.08% | 48,281 | $0.65 | $0.65 | $0.63 |
| 28 Jan 2026 | $0.65 | $0.00 | 0.00% | 1,749 | $0.65 | $0.65 | $0.65 |
| 27 Jan 2026 | $0.65 | $-0.01 | -1.52% | 14,242 | $0.66 | $0.66 | $0.65 |
| 23 Jan 2026 | $0.66 | $-0.01 | -1.49% | 12,022 | $0.67 | $0.67 | $0.66 |
| 22 Jan 2026 | $0.67 | $-0.01 | -1.47% | 12,401 | $0.68 | $0.68 | $0.67 |
| 21 Jan 2026 | $0.68 | $-0.01 | -1.44% | 3,942 | $0.68 | $0.68 | $0.68 |
| 20 Jan 2026 | $0.70 | $-0.01 | -1.43% | 7,746 | $0.70 | $0.70 | $0.70 |
| 19 Jan 2026 | $0.70 | $-0.01 | -1.42% | 19,419 | $0.70 | $0.70 | $0.70 |
| 16 Jan 2026 | $0.71 | $0.00 | 0.00% | 67,821 | $0.71 | $0.71 | $0.70 |
| 15 Jan 2026 | $0.71 | $0.02 | 2.90% | 27,208 | $0.69 | $0.71 | $0.69 |
| 14 Jan 2026 | $0.69 | $0.00 | 0.00% | 4,541 | $0.69 | $0.69 | $0.69 |
| 13 Jan 2026 | $0.69 | $0.00 | 0.00% | 66,935 | $0.70 | $0.71 | $0.69 |
| 12 Jan 2026 | $0.69 | $-0.02 | -2.84% | 6,128 | $0.69 | $0.69 | $0.69 |
| 09 Jan 2026 | $0.71 | $-0.01 | -1.41% | 38,178 | $0.71 | $0.71 | $0.71 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 26 Nov 2025 | Stephen Tomisich | Buy | 13,569 | $8,819 |
On-market trade.
|
| 25 Nov 2025 | Stephen Tomisich | Buy | 24,055 | $15,631 |
On-market trade.
|
| 19 Nov 2025 | Tiffiny Lewin | Issued | 63,875 | $41,518 |
Issue of options.
|
| 19 Nov 2025 | Rohit Khanna | Issued | 63,875 | $41,518 |
Issue of options.
|
| 19 Nov 2025 | Stephen Tomisich | Buy | 62,482 | $40,600 |
On-market trade.
|
| 19 Nov 2025 | John Eales | Issued | 95,813 | $62,278 |
Issue of options.
|
| 11 Sep 2025 | Sara Watts | Exercise | 82,493 | $65,994 |
Exercise of options.
|
| 11 Sep 2025 | Sara Watts | Buy | 82,493 | $65,994 |
Exercise of options.
|
| 11 Sep 2025 | John Eales | Exercise | 79,533 | $63,626 |
Exercise of options.
|
| 11 Sep 2025 | John Eales | Buy | 79,533 | $63,626 |
Exercise of options.
|
| 02 Apr 2025 | Tiffiny Lewin | Buy | 29,471 | $24,460 |
Exercise of options.
|
| 02 Apr 2025 | Tiffiny Lewin | Exercise | 29,471 | $24,460 |
Exercise of options.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Robert (Bob) John Lyon | Head of Corporate Development and General CounselExecutive Director | Sep 2014 |
Mr lyon has global responsibility for the strategic growth of Trajan's business through mergers and acquisitions, licensing arrangements, and commercial relationships with Trajan's industry, academic, government and research partners in the scientific and medical sectors globally. As Trajan's General Counsel he also has responsibility for the negotiation and execution of Trajan's investments and transactions, as well as for its broader legal requirements.
|
| Mr John Anthony Eales | Non-Executive ChairmanNon-Executive Director | Mar 2021 |
Mr Eales has served as an executive, adviser, director and investor in several listed public companies and unlisted private organisations. He co-founded the Mettle Group in 2003, a corporate consultancy which was acquired by Chandler Macleod in 2007. He is the Chair of the World Rugby Hall of Fame Selection Panel and was on the Rugby Australia Bid Advisory Board for the Rugby World Cup 2027. He was made a Member of the Order of Australia in 1999 for services to the community and rugby and is a Patron of the Melanoma Foundation, Hearts in Union and the Champagnat Trust. He is also a member of the Risk Committee.
|
| Mr Rohit Khanna | Non-Executive Director | Mar 2021 |
Dr Khanna has 40 years of experience in analytical science, business leadership and laboratory application software. In 1981, he co-founded Dynamic Solutions, a software-engineering firm dedicated to providing computing solutions to the scientific and engineering community. He went on to hold various senior management roles at Waters Corporation, including Vice-President and General Manager of the Data Products Group. In 2002, he was appointed Vice-President, Worldwide Marketing, and most recently he was Senior Vice President of several key Waters Corporation businesses including Informatics, Service, and Chemistry, along with being a member of the Corporate Executive Committee. He is also a member of the Risk Committee.
|
| Mr Stephen Andrew Tomisich | Chief Executive OfficerManaging Director | Aug 2011 |
Mr Tomisich is responsible for the design and implementation of Trajan's strategic business plan and overall leadership of the organisation.
|
| Ms Tiffiny Jane Lewin | Non-Executive Director | Mar 2021 |
Ms Lewin brings operational, risk and strategy 30-year career spanning consumer goods, manufacturing, professional services and the finance sectors. She is currently a senior leader at Westpac Group where she has served since 2015. Prior to Westpac, Tiffiny held senior leadership, operational and strategy roles across Australia and Asia for global organisations including Nestle Australia, Nestle Japan, SCA Hygiene, Mondelez International and Procter & Gamble where she successfully delivered organisational transformation, performance turnaround and market growth across business and consumer sectors. She is also a member of the Risk Committee.
|
| Mr Mark Andrew Licciardo | Joint Company Secretary | Jun 2021 |
-
|
| Mr Alister John Hodges | Chief Financial OfficerJoint Company Secretary | Jun 2021 |
-
|
| Alister John Hodges | Chief Financial OfficerJoint Company Secretary |
-
|
|
| Mark Andrew Licciardo | Joint Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Tomisich Family Pty Ltd | 76,878,745 | 50.45% |
| HSBC Custody Nominees (Australia) Limited | 17,269,035 | 11.33% |
| J P Morgan Nominees Australia Pty Limited | 12,091,141 | 7.93% |
| Citicorp Nominees Pty Limited | 11,778,334 | 7.73% |
| Farrona Llc | 4,659,843 | 3.06% |
| Telunapa Pty Ltd <Telunapa Capital A/C> | 1,700,000 | 1.12% |
| Ruck & Maul Pty Ltd <The John Eales Family A/C> | 1,151,553 | 0.76% |
| Mr Alister John Hodges | 678,525 | 0.45% |
| Investment Holdings Pty Ltd Investment Holdings Unit A/C> | 615,000 | 0.40% |
| Investment Society One Pty Ltd Investment Society One A/C> | 500,000 | 0.33% |
| Redbrook Nominees Pty Ltd | 450,000 | 0.30% |
| Invia Custodian Pty Limited <Mj Sherwin Family A/C> | 350,000 | 0.23% |
| Devonport Central Pty Ltd <Chas & Robyn Kelly Fam A/C> | 319,856 | 0.21% |
| Bnp Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> | 319,280 | 0.21% |
| Lyon Super Fund Pty Ltd <Lyon Family Super Fund A/C> | 316,470 | 0.21% |
| Mr Simon Conn <Skc Investment A/C> | 300,000 | 0.20% |
| Prineas Super Pty Ltd <Prineas Super Fund A/C> | 300,000 | 0.20% |
| Luisthan Pty Ltd <Morris S/F A/C> | 300,000 | 0.20% |
| BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> | 293,816 | 0.19% |
| Jummysue Pty Ltd <Scurry Superannuation A/C> | 288,000 | 0.19% |
